Regarding sex, females carrying the IL-6-C-allele were more likely to have NSCLC susceptibility compared to males in the dominant model (adjusted, OR 7.0, p = 0.005, CC + GC vs. GG). Here, IL6 is linked to non-small cell lung carcinoma.